Ultima-Selank 5mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE Selank

For your safety, products are shipped without brand labels. The burgeoning field of biotechnology has paved the way for innovative biologically-active compounds, including popular "cognitive enhancers" or "nootropics."

Among these, Selank, previously known as "TP-7," stands out as a synthetic peptide?a small, man-made protein recognized for its potential benefits.

Promoted as an anti-anxiety solution, Selank is also said to enhance cognitive function and boost energy levels?all without the risk of side effects or addiction.

This peptide is notably smaller than most natural proteins and was developed through collaborative research at the Institute of Molecular Genetics and the V.V. Zakusov Research Institute of Pharmacology in Russia, alongside its counterpart, Semax.

Selank's formulation combines the peptide sequence of tuftsin, which is naturally present in the body and part of the antibody IgG, with a stability-enhancing sequence. Both tuftsin and Selank have demonstrated the ability to reduce anxiety and elevate serotonin levels in animal studies, with Selank showing enhanced effectiveness.

In Russia, Selank is approved for treating generalized anxiety disorder (GAD) and is recognized as a nootropic. Though it lacks FDA approval for any particular conditions, Selank remains available in various countries, often marketed as a "nutritional supplement."

While the exact mechanisms behind Selank's action are not completely understood, it is believed to stabilize enkephalins in the bloodstream?natural peptides that help mitigate stress.

However, one mouse study failed to confirm the stabilization of enkephalins post-Selank administration, showing no significant anti-anxiety effects. Other research indicates that Selank may interact with GABA receptors, which are associated with sedative effects. A study in mice found that Selank increased activity in GABA-dependent inhibitory neurons, leading to decreased overall brain activity, consistent with sedative properties.

Additionally, researchers have noted an increase in BDNF, a neurotrophic factor pivotal for learning and memory, which may explain some cognitive benefits linked to Selank.

Selank also appears to influence levels of norepinephrine, dopamine, and serotonin in animal studies?neurotransmitters crucial for motivation, focus, and pleasure. One study revealed mixed effects on these neurotransmitters, highlighting the need for further exploration of Selank's specific impacts.

A preliminary clinical trial involving 62 participants found that those treated with Selank reported a noticeable reduction in anxiety symptoms, especially among individuals with pre-existing anxiety disorders. Another study with 60 anxious patients observed similar benefits that lasted up to a week after treatment. A third trial involving 70 anxiety patients noted that Selank enhanced the effects of phenazepam, an anti-anxiety medication (restricted in some U.S. states), while minimizing side effects like drowsiness and memory issues.

In animal studies, Selank has shown promise in reducing anxiety in mice, with more pronounced behavioral changes in those with higher anxiety levels. Its anti-anxiety effects have also been observed in rats undergoing daily treatment for four weeks.

While evidence is still limited, it suggests that Selank may be helpful in alleviating anxiety. However, more research is essential to confirm its effectiveness and safety in humans. If you struggle with anxiety, consult your healthcare provider to determine if Selank could be a beneficial addition to your treatment plan, ensuring it complements prescribed therapies.

In a 30-day study, Selank reportedly helped stabilize memory traces in rats, potentially enhancing memory retention, although specific measurement details remain unclear. Another study indicated it might assist in memory preservation in monkeys.

Human studies are currently insufficient, leaving the effects of Selank on healthy users uncertain. Its safety for such individuals over short or long terms is not fully established, warranting caution until further research is conducted.

Research indicates that Selank can normalize brain activity in rats with toxin-induced brain damage.

In animal studies, Selank has been observed to reduce depressive symptoms?assessed through immobility in forced swimming tests?showing greater effectiveness at lower doses.

In one preliminary study, Selank injections led to increased antioxidant levels in the livers of stressed mice.

In sedated cats, Selank was shown to reduce blood pressure by approximately 30% for up to three minutes and to enhance brain blood flow by about 24% for up to ten minutes. While these initial findings suggest potential cardiovascular effects, their short duration raises questions about their clinical significance. Additionally, these observations are limited to animal studies, leaving its effects on healthy humans uncertain.

Anxiety is a common symptom during alcohol withdrawal. A study involving rats given a 10% ethanol solution for 24 weeks demonstrated that Selank alleviated anxiety symptoms following a 48-hour withdrawal period.

In another animal study, Selank-treated rats on a high-fat diet experienced 35% less weight gain, with total cholesterol levels dropping by over 58% and blood glucose levels decreasing by 23.5%.

A study involving breast cancer-affected mice found that those receiving Selank exhibited slower tumor growth and longer lifespans compared to untreated counterparts. However, this does not confirm any anticancer properties of Selank, necessitating extensive research before considering it a viable treatment option, and it should not replace standard cancer therapies.

Post-treatment with Selank revealed increased levels of inflammatory response genes in the spleens of mice, suggesting potential protective benefits against inflammation.

Selank has demonstrated the ability to reduce the size of stomach ulcers in animal models, likely by enhancing lymph flow to the stomach?a vital component of immune function. However, comprehensive human studies are needed to validate these effects and their underlying mechanisms.

Selank was found to elevate IL-6 levels in blood cells from patients with depression. IL-6 is an inflammatory protein that may help combat infections. Moreover, in one cell-based study, Selank stimulated the release of interferons, which are molecules that fight viral infections.

While there are indications that Selank could offer some protection against specific viral infections, results from animal studies involving virus-infected mice have raised questions about its antiviral efficacy. Further research is essential to fully assess Selank's potential and limitations.